1905
METHODS : Stage IIIb or IV NSCLC patients , with two or fewer prior chemotherapy regimens , one platinum based ( stratum 1 ) or both chemotherapy and epidermal growth factor receptor tyrosine kinase inhibitors ( stratum 2 ) , received RAD001 10 mg / day until progression or unacceptable toxicity .
 Disease: NSCLC; Chemical: platinum; Chemical: tyrosine; Chemical: RAD001; Disease: toxicity
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Disease: NSCLC; Chemical: platinum; Chemical: tyrosine; Chemical: RAD001; Disease: toxicity